Alpha-Methyldopa and Hydrochlorothiazide

Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanine

1960 • 254 citations

Clinical and Chemical Studies with α -Methyl-Dopa in Patients with Hypertension

1962 • 146 citations

Effect of Alpha-Methyl DOPA in Severe and Malignant Hypertension

1962 • 88 citations

Pharmacodynamic effects of alpha-methyl dopa in hypertensive subjects

1964 • 80 citations

Hemodynamic Effects of Methyldopa (Aldomet®) at Rest and during Exercise in Patients with Arterial Hypertension

1962 • 59 citations

Treatment of Severe Hypertension with Methyldopa

1963 • 52 citations

Alpha-Methyl Dopa for the Treatment of Hypertension

1963 • 50 citations

Hypotensive Action of Methyldopa

1963 • 50 citations

Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension∗

1962 • 46 citations

HAeMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES

1963 • 43 citations

Methyldopa for Treatment of Hypertension

1963 • 34 citations

Methyldopa in hypertension

1963 • 29 citations

Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa

1962 • 28 citations

Methyldopa in the Treatment of Hypertension

1963 • 28 citations

Methyldopa and Hydrochlorothiazide in Primary Hypertension

1963 • 23 citations

Decarboxylase inhibitors in the treatment of hypertension∗

1962 • 12 citations